Results 191 to 200 of about 161,125 (296)
Pharmacological Therapy in Patients With Gender Dysphoria: A Cohort Study in the Lazio Region, Italy. [PDF]
Belleudi V +4 more
europepmc +1 more source
An RVG‑engineered exosomal saRNA delivery system (RVG‑EVs‑saPtpro) effectively targets and activates hippocampal PTPRO, functioning as a “molecular brake” to alleviate cancer therapy‑related cognitive impairment (CTRCI) by enhancing neuronal survival, neurogenesis, and synaptic plasticity.
Zhimeng Yao +18 more
wiley +1 more source
Autism Spectrum Disorder and Life Expectancy Among Medicaid Beneficiaries.
Li G +4 more
europepmc +1 more source
Gut microbiota as a therapeutic target in sepsis-induced multi-organ dysfunction: a review. [PDF]
Zhao X, Ma T, Yu J, Hu Y.
europepmc +1 more source
This review identifies current and future directions in abiotic nanostructured catalysts to develop reliable and sustainable glucose fuel cells to power the next generation of bioelectronic devices. ABSTRACT The global rise in incidence of chronic diseases has led to the demand for innovative solutions that help patients manage their conditions with ...
Asghar Niyazi +3 more
wiley +1 more source
Integrating mechanical cues in <i>in vitro</i> models of immune-related fibrotic diseases. [PDF]
Song C +8 more
europepmc +1 more source
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang +14 more
wiley +1 more source
Gut-reproduction axis: a new perspective on understanding pelvic inflammatory disease. [PDF]
Ma S +8 more
europepmc +1 more source
This work establishes a novel method for generating multicellular liver organoids from control and MASH donor iPSCs. The model recapitulates several disease‐specific characteristics, with MASH donor‐derived organoids showing higher susceptibility. Lipidomic profiling of MASH organoids closely resembles MASH liver biopsies.
Ekta Minocha +5 more
wiley +1 more source
Advances in vascularized organoids. [PDF]
Shen L, Ma J, Wei X, Shi G, Deng H.
europepmc +1 more source

